Advisor Group’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | $2.89M | Sell |
30,401
-1,840
| -6% | -$175K | 0.02% | 645 |
|
|
2019
Q3 | $2.46M | Sell |
32,241
-10,045
| -24% | -$766K | 0.02% | 674 |
|
|
2019
Q2 | $3.71M | Sell |
42,286
-17,082
| -29% | -$1.5M | 0.03% | 509 |
|
|
2019
Q1 | $5.38M | Buy |
59,368
+21,395
| +56% | +$1.94M | 0.04% | 357 |
|
|
2018
Q4 | $2.73M | Sell |
37,973
-213
| -0.6% | -$15.3K | 0.03% | 511 |
|
|
2018
Q3 | $3.66M | Sell |
38,186
-2,925
| -7% | -$280K | 0.04% | 428 |
|
|
2018
Q2 | $3.92M | Buy |
41,111
+1,058
| +3% | +$101K | 0.05% | 314 |
|
|
2018
Q1 | $3.52M | Sell |
40,053
-5,271
| -12% | -$463K | 0.05% | 351 |
|
|
2017
Q4 | $3.85M | Buy |
45,324
+11,213
| +33% | +$951K | 0.05% | 333 |
|
|
2017
Q3 | $2.95M | Buy |
34,111
+2,871
| +9% | +$249K | 0.05% | 364 |
|
|
2017
Q2 | $2.41M | Sell |
31,240
-26,555
| -46% | -$2.05M | 0.04% | 423 |
|
|
2017
Q1 | $4.01M | Buy |
57,795
+34,710
| +150% | +$2.41M | 0.08% | 256 |
|
|
2016
Q4 | $1.37M | Sell |
23,085
-724
| -3% | -$42.9K | 0.03% | 542 |
|
|
2016
Q3 | $1.58M | Buy |
23,809
+1,223
| +5% | +$81.1K | 0.04% | 479 |
|
|
2016
Q2 | $1.22M | Buy |
+22,586
| New | +$1.22M | 0.03% | 544 |
|